Trulieve Cannabis is trading 4.1% lower at $10.34 amid weakness across cannabis stocks on October 8, 2026.
- No clearly reported company-specific announcement explained the intraday decline. The MSOS cannabis ETF was down 2.35% at 10:55 a.m. ET; an earlier DEA rescheduling pause remains a sector-wide overhang, not a new company-specific catalyst.
- Geopolitical tensions, elevated oil prices and Treasury yields may weigh on sentiment; major U.S. indexes were down less than 0.5%. No reliable volume detail was available.